National Workshop on Good Clinical Practice (GCP) 2025

Date:

Share post:

National Workshop on Good Clinical Practice (GCP) 2025

Date: 02.08.2025

Time: 9.30 AM – 4.30 PM

Venue: K. P. BASU Memorial Hall, Jadavpur University (Offline)

Online : Online Live Streaming(Google Meet)  

Organized By :
PharmaGenDRx & ABS Clinical Solutions
In Association With : Bioequivalence Study Centre, Jadavpur University

 

    • Keynote Speakers:
    • Prof. (Dr.) Suparna Chatterjee, Dept. of Pharmacology, IPGMER Kolkata
    • Prof. (Dr.) Avijit Hazra, Dean of Student Affairs, IPGMER-SSKM Hospital
    • Dr. Supriyo Chowdhury, Asst. Director Research, Institute of Neurosciences, Kolkata
    • Prof. (Dr.) Arunava Biswas, MD,DM,HOD Barasat Medical College & Hospital

  •  

  •  

REGISTRATION DETAILS :
For Offline Attendees-
Student – Rs. 799 (Early Bird Registration till 5th July, 2025)
  Rs. 899  (Final Registration)
Academia & Industry –  Rs.1199 (Early Bird Registration till 5th July, 2025)
Rs. 1299 (Final Registration)

For Online Attendees –
Student – Rs. 499 (Early Bird Registration till 5th July, 2025)
  Rs. 599  (Final Registration)
Academia & Industry –  Rs. 799 (Early Bird Registration till 5th July, 2025)
Rs. 899 (Final Registration)


Each Participants will get Certificate for Participation from Jadavpur University Bioequivalence Study Centre.
Offline Participants will be provided with breakfast, lunch, and tea during the workshop.  
Registration fees are non-refundable.

 

Registration Here : https://docs.google.com/forms/d/18DbD6nv1T_TeLqB3lm6M6ewXfTLKC16tixZKCv5Y40g/viewform?edit_requested=true

Digital Media Partners : PharmaTutor, Being Pharmacist, Pharmacist Tanyeem

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility...

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Wockhardt Limited  announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic...

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the...

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing...